Evaluation of screening instruments for depression and anxiety in breast cancer survivors
Although cases of anxiety and depression post-breast cancer can be reliably identified using a structured psychiatric interview, such interviews are time consuming for both practitioner and patient and effective screening tools would increase detection rates. The purpose of this study was to evaluat...
Gespeichert in:
| Veröffentlicht in: | Breast cancer research and treatment 2010-07, Vol.122 (2), p.573-578 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 578 |
|---|---|
| container_issue | 2 |
| container_start_page | 573 |
| container_title | Breast cancer research and treatment |
| container_volume | 122 |
| creator | Alexander, Susanna Palmer, Clare Stone, Patrick C. |
| description | Although cases of anxiety and depression post-breast cancer can be reliably identified using a structured psychiatric interview, such interviews are time consuming for both practitioner and patient and effective screening tools would increase detection rates. The purpose of this study was to evaluate the effectiveness of the Edinburgh Depression Scale (EDS) and the Hospital Anxiety and Depression Scale (HADS) in screening for depression and anxiety in a population of breast cancer survivors. For this purpose, The Structured Clinical Interview for the Diagnostic and Statistical Manual of mental disorders was administered to 200 breast cancer survivors to identify those suffering from an anxiety and/or depressive disorder. All study participants also completed the EDS and the HADS. Using the recommended cut-off score of >12 to screen for depression, the sensitivity and specificity of the EDS were found to be 72 and 90%, respectively. Lowering the cut-off score to >9 resulted in a sensitivity of 94% and a specificity of 78%. At the recommended cut-off score of >10, the HADS had a sensitivity of 50% and a specificity of 97% for depression, and a sensitivity of 71% and a specificity of 86% when screening for anxiety. A HADS total score (HADS-T) of >13 and an EDS of >9 had sensitivities of 96 and 91% and specificities of 74 and 84%, respectively, in screening for anxiety and/or depression. In conclusion, the study demonstrated that both the EDS and HADS can be used reliably as screening tests for anxiety and depression in this cohort. In both cases, a lower cut-off score than normally recommended delivers optimal screening properties. |
| doi_str_mv | 10.1007/s10549-009-0669-6 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_00535422v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A470512025</galeid><sourcerecordid>A470512025</sourcerecordid><originalsourceid>FETCH-LOGICAL-c663t-6d1f11e1cca581a07a7d38a34d69723e2aa53039be06e23d49b6055806a900173</originalsourceid><addsrcrecordid>eNqN0l9v0zAQAPAIgdgYfABeUMTEv4eMsx3b9WM1DYZUiRd44MlynUvrKbWLnVTs2-Mo1dYhqFB0iuT87hz7riheErggAPJjIsBrVQHkEEJV4lFxSrhklaREPi5OgQhZiRmIk-JZSjeQoQT1tDghSgmgNTstflztTDeY3gVfhrZMNiJ651el86mPwwZ9n8o2xLLBbcSURmd8k-OXw_42s3IZ0aS-tMZbjGUa4s7tQkzPiyet6RK-2L_Piu-frr5dXleLr5-_XM4XlRWC9ZVoSEsIEmsNnxED0siGzQyrG6EkZUiN4QyYWiIIpKyp1VIA5_lQRgEQyc6KD1Pdten0NrqNibc6GKev5ws9rgFwxmtKdyTbd5PdxvBzwNTrjUsWu854DEPSkjFW84yzfH9UkhkhCiib8Uxf_0FvwhB9PrPmQBinVI3ofEIr06F2vg19NHasqee1BE4o0OOKcUGFkHT8t4u_qPw0uHE2eGxdXn9Q9r8SDnd4e5CwRtP16xS6YRyT9LDyUXhYkUzQxpBSxPauVQT0OMx6GubcrRx5mLXIOa_2FzssN9jcZ-ynN4M3e2CSNV0b8wi6dOfyxdd1rpcdnVzKn_wK432H_r37b9LeBNM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>501352295</pqid></control><display><type>article</type><title>Evaluation of screening instruments for depression and anxiety in breast cancer survivors</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Alexander, Susanna ; Palmer, Clare ; Stone, Patrick C.</creator><creatorcontrib>Alexander, Susanna ; Palmer, Clare ; Stone, Patrick C.</creatorcontrib><description>Although cases of anxiety and depression post-breast cancer can be reliably identified using a structured psychiatric interview, such interviews are time consuming for both practitioner and patient and effective screening tools would increase detection rates. The purpose of this study was to evaluate the effectiveness of the Edinburgh Depression Scale (EDS) and the Hospital Anxiety and Depression Scale (HADS) in screening for depression and anxiety in a population of breast cancer survivors. For this purpose, The Structured Clinical Interview for the Diagnostic and Statistical Manual of mental disorders was administered to 200 breast cancer survivors to identify those suffering from an anxiety and/or depressive disorder. All study participants also completed the EDS and the HADS. Using the recommended cut-off score of >12 to screen for depression, the sensitivity and specificity of the EDS were found to be 72 and 90%, respectively. Lowering the cut-off score to >9 resulted in a sensitivity of 94% and a specificity of 78%. At the recommended cut-off score of >10, the HADS had a sensitivity of 50% and a specificity of 97% for depression, and a sensitivity of 71% and a specificity of 86% when screening for anxiety. A HADS total score (HADS-T) of >13 and an EDS of >9 had sensitivities of 96 and 91% and specificities of 74 and 84%, respectively, in screening for anxiety and/or depression. In conclusion, the study demonstrated that both the EDS and HADS can be used reliably as screening tests for anxiety and depression in this cohort. In both cases, a lower cut-off score than normally recommended delivers optimal screening properties.</description><identifier>ISSN: 0167-6806</identifier><identifier>EISSN: 1573-7217</identifier><identifier>DOI: 10.1007/s10549-009-0669-6</identifier><identifier>PMID: 19960243</identifier><identifier>CODEN: BCTRD6</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adult ; Adult and adolescent clinical studies ; Aged ; Aged, 80 and over ; Anxiety ; Anxiety - diagnosis ; Anxiety - etiology ; Biological and medical sciences ; Breast cancer ; Breast Neoplasms - psychology ; Breast Neoplasms - therapy ; Brief Report ; Cancer ; Cancer research ; Cancer survivors ; Cancer therapies ; Depression ; Depression - diagnosis ; Depression - etiology ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; London ; Mammary gland diseases ; Medical sciences ; Medical screening ; Medicine ; Medicine & Public Health ; Mental depression ; Mental illness ; Middle Aged ; Mood disorders ; Oncology ; Oncology, Experimental ; Predictive Value of Tests ; Psychiatric Status Rating Scales ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Reproducibility of Results ; Sensitivity and Specificity ; Surveys and Questionnaires ; Survivors - psychology ; Treatment Outcome ; Tumors</subject><ispartof>Breast cancer research and treatment, 2010-07, Vol.122 (2), p.573-578</ispartof><rights>Springer Science+Business Media, LLC. 2009</rights><rights>2015 INIST-CNRS</rights><rights>COPYRIGHT 2010 Springer</rights><rights>Springer Science+Business Media, LLC. 2010</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c663t-6d1f11e1cca581a07a7d38a34d69723e2aa53039be06e23d49b6055806a900173</citedby><cites>FETCH-LOGICAL-c663t-6d1f11e1cca581a07a7d38a34d69723e2aa53039be06e23d49b6055806a900173</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10549-009-0669-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10549-009-0669-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22944009$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19960243$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00535422$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Alexander, Susanna</creatorcontrib><creatorcontrib>Palmer, Clare</creatorcontrib><creatorcontrib>Stone, Patrick C.</creatorcontrib><title>Evaluation of screening instruments for depression and anxiety in breast cancer survivors</title><title>Breast cancer research and treatment</title><addtitle>Breast Cancer Res Treat</addtitle><addtitle>Breast Cancer Res Treat</addtitle><description>Although cases of anxiety and depression post-breast cancer can be reliably identified using a structured psychiatric interview, such interviews are time consuming for both practitioner and patient and effective screening tools would increase detection rates. The purpose of this study was to evaluate the effectiveness of the Edinburgh Depression Scale (EDS) and the Hospital Anxiety and Depression Scale (HADS) in screening for depression and anxiety in a population of breast cancer survivors. For this purpose, The Structured Clinical Interview for the Diagnostic and Statistical Manual of mental disorders was administered to 200 breast cancer survivors to identify those suffering from an anxiety and/or depressive disorder. All study participants also completed the EDS and the HADS. Using the recommended cut-off score of >12 to screen for depression, the sensitivity and specificity of the EDS were found to be 72 and 90%, respectively. Lowering the cut-off score to >9 resulted in a sensitivity of 94% and a specificity of 78%. At the recommended cut-off score of >10, the HADS had a sensitivity of 50% and a specificity of 97% for depression, and a sensitivity of 71% and a specificity of 86% when screening for anxiety. A HADS total score (HADS-T) of >13 and an EDS of >9 had sensitivities of 96 and 91% and specificities of 74 and 84%, respectively, in screening for anxiety and/or depression. In conclusion, the study demonstrated that both the EDS and HADS can be used reliably as screening tests for anxiety and depression in this cohort. In both cases, a lower cut-off score than normally recommended delivers optimal screening properties.</description><subject>Adult</subject><subject>Adult and adolescent clinical studies</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anxiety</subject><subject>Anxiety - diagnosis</subject><subject>Anxiety - etiology</subject><subject>Biological and medical sciences</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - psychology</subject><subject>Breast Neoplasms - therapy</subject><subject>Brief Report</subject><subject>Cancer</subject><subject>Cancer research</subject><subject>Cancer survivors</subject><subject>Cancer therapies</subject><subject>Depression</subject><subject>Depression - diagnosis</subject><subject>Depression - etiology</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>London</subject><subject>Mammary gland diseases</subject><subject>Medical sciences</subject><subject>Medical screening</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Mental depression</subject><subject>Mental illness</subject><subject>Middle Aged</subject><subject>Mood disorders</subject><subject>Oncology</subject><subject>Oncology, Experimental</subject><subject>Predictive Value of Tests</subject><subject>Psychiatric Status Rating Scales</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Reproducibility of Results</subject><subject>Sensitivity and Specificity</subject><subject>Surveys and Questionnaires</subject><subject>Survivors - psychology</subject><subject>Treatment Outcome</subject><subject>Tumors</subject><issn>0167-6806</issn><issn>1573-7217</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqN0l9v0zAQAPAIgdgYfABeUMTEv4eMsx3b9WM1DYZUiRd44MlynUvrKbWLnVTs2-Mo1dYhqFB0iuT87hz7riheErggAPJjIsBrVQHkEEJV4lFxSrhklaREPi5OgQhZiRmIk-JZSjeQoQT1tDghSgmgNTstflztTDeY3gVfhrZMNiJ651el86mPwwZ9n8o2xLLBbcSURmd8k-OXw_42s3IZ0aS-tMZbjGUa4s7tQkzPiyet6RK-2L_Piu-frr5dXleLr5-_XM4XlRWC9ZVoSEsIEmsNnxED0siGzQyrG6EkZUiN4QyYWiIIpKyp1VIA5_lQRgEQyc6KD1Pdten0NrqNibc6GKev5ws9rgFwxmtKdyTbd5PdxvBzwNTrjUsWu854DEPSkjFW84yzfH9UkhkhCiib8Uxf_0FvwhB9PrPmQBinVI3ofEIr06F2vg19NHasqee1BE4o0OOKcUGFkHT8t4u_qPw0uHE2eGxdXn9Q9r8SDnd4e5CwRtP16xS6YRyT9LDyUXhYkUzQxpBSxPauVQT0OMx6GubcrRx5mLXIOa_2FzssN9jcZ-ynN4M3e2CSNV0b8wi6dOfyxdd1rpcdnVzKn_wK432H_r37b9LeBNM</recordid><startdate>20100701</startdate><enddate>20100701</enddate><creator>Alexander, Susanna</creator><creator>Palmer, Clare</creator><creator>Stone, Patrick C.</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><general>Springer Verlag</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope></search><sort><creationdate>20100701</creationdate><title>Evaluation of screening instruments for depression and anxiety in breast cancer survivors</title><author>Alexander, Susanna ; Palmer, Clare ; Stone, Patrick C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c663t-6d1f11e1cca581a07a7d38a34d69723e2aa53039be06e23d49b6055806a900173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult</topic><topic>Adult and adolescent clinical studies</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anxiety</topic><topic>Anxiety - diagnosis</topic><topic>Anxiety - etiology</topic><topic>Biological and medical sciences</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - psychology</topic><topic>Breast Neoplasms - therapy</topic><topic>Brief Report</topic><topic>Cancer</topic><topic>Cancer research</topic><topic>Cancer survivors</topic><topic>Cancer therapies</topic><topic>Depression</topic><topic>Depression - diagnosis</topic><topic>Depression - etiology</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>London</topic><topic>Mammary gland diseases</topic><topic>Medical sciences</topic><topic>Medical screening</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Mental depression</topic><topic>Mental illness</topic><topic>Middle Aged</topic><topic>Mood disorders</topic><topic>Oncology</topic><topic>Oncology, Experimental</topic><topic>Predictive Value of Tests</topic><topic>Psychiatric Status Rating Scales</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Reproducibility of Results</topic><topic>Sensitivity and Specificity</topic><topic>Surveys and Questionnaires</topic><topic>Survivors - psychology</topic><topic>Treatment Outcome</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alexander, Susanna</creatorcontrib><creatorcontrib>Palmer, Clare</creatorcontrib><creatorcontrib>Stone, Patrick C.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Breast cancer research and treatment</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alexander, Susanna</au><au>Palmer, Clare</au><au>Stone, Patrick C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of screening instruments for depression and anxiety in breast cancer survivors</atitle><jtitle>Breast cancer research and treatment</jtitle><stitle>Breast Cancer Res Treat</stitle><addtitle>Breast Cancer Res Treat</addtitle><date>2010-07-01</date><risdate>2010</risdate><volume>122</volume><issue>2</issue><spage>573</spage><epage>578</epage><pages>573-578</pages><issn>0167-6806</issn><eissn>1573-7217</eissn><coden>BCTRD6</coden><abstract>Although cases of anxiety and depression post-breast cancer can be reliably identified using a structured psychiatric interview, such interviews are time consuming for both practitioner and patient and effective screening tools would increase detection rates. The purpose of this study was to evaluate the effectiveness of the Edinburgh Depression Scale (EDS) and the Hospital Anxiety and Depression Scale (HADS) in screening for depression and anxiety in a population of breast cancer survivors. For this purpose, The Structured Clinical Interview for the Diagnostic and Statistical Manual of mental disorders was administered to 200 breast cancer survivors to identify those suffering from an anxiety and/or depressive disorder. All study participants also completed the EDS and the HADS. Using the recommended cut-off score of >12 to screen for depression, the sensitivity and specificity of the EDS were found to be 72 and 90%, respectively. Lowering the cut-off score to >9 resulted in a sensitivity of 94% and a specificity of 78%. At the recommended cut-off score of >10, the HADS had a sensitivity of 50% and a specificity of 97% for depression, and a sensitivity of 71% and a specificity of 86% when screening for anxiety. A HADS total score (HADS-T) of >13 and an EDS of >9 had sensitivities of 96 and 91% and specificities of 74 and 84%, respectively, in screening for anxiety and/or depression. In conclusion, the study demonstrated that both the EDS and HADS can be used reliably as screening tests for anxiety and depression in this cohort. In both cases, a lower cut-off score than normally recommended delivers optimal screening properties.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>19960243</pmid><doi>10.1007/s10549-009-0669-6</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0167-6806 |
| ispartof | Breast cancer research and treatment, 2010-07, Vol.122 (2), p.573-578 |
| issn | 0167-6806 1573-7217 |
| language | eng |
| recordid | cdi_hal_primary_oai_HAL_hal_00535422v1 |
| source | MEDLINE; SpringerLink Journals |
| subjects | Adult Adult and adolescent clinical studies Aged Aged, 80 and over Anxiety Anxiety - diagnosis Anxiety - etiology Biological and medical sciences Breast cancer Breast Neoplasms - psychology Breast Neoplasms - therapy Brief Report Cancer Cancer research Cancer survivors Cancer therapies Depression Depression - diagnosis Depression - etiology Female Gynecology. Andrology. Obstetrics Humans London Mammary gland diseases Medical sciences Medical screening Medicine Medicine & Public Health Mental depression Mental illness Middle Aged Mood disorders Oncology Oncology, Experimental Predictive Value of Tests Psychiatric Status Rating Scales Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Reproducibility of Results Sensitivity and Specificity Surveys and Questionnaires Survivors - psychology Treatment Outcome Tumors |
| title | Evaluation of screening instruments for depression and anxiety in breast cancer survivors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T01%3A30%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20screening%20instruments%20for%20depression%20and%20anxiety%20in%20breast%20cancer%20survivors&rft.jtitle=Breast%20cancer%20research%20and%20treatment&rft.au=Alexander,%20Susanna&rft.date=2010-07-01&rft.volume=122&rft.issue=2&rft.spage=573&rft.epage=578&rft.pages=573-578&rft.issn=0167-6806&rft.eissn=1573-7217&rft.coden=BCTRD6&rft_id=info:doi/10.1007/s10549-009-0669-6&rft_dat=%3Cgale_hal_p%3EA470512025%3C/gale_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=501352295&rft_id=info:pmid/19960243&rft_galeid=A470512025&rfr_iscdi=true |